Evidence map›Paper›PMID 27531743›Full record

ArticleThe Journal of biological chemistry2016

The Impact of N-terminal Acetylation of α-Synuclein on Phospholipid Membrane Binding and Fibril Structure.

Aditya Iyer, Steven J Roeters, Nathalie Schilderink, Bob Hommersom, Ron M A Heeren, Sander Woutersen, Mireille M A E Claessens, Vinod Subramaniam

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. ZnJournal of the American Chemical Society · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Aditya IyerFrom the Nanoscale Biophysics Group, FOM Institute AMOLF, Amsterdam, the Nanobiophysics Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede.
Steven J Roetersthe Van't Hoff Institute for Molecular Sciences, University of Amsterdam, Amsterdam.
Nathalie Schilderinkthe Nanobiophysics Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede.
Bob Hommersomthe BioImaging MS Group, FOM Institute AMOLF, Amsterdam, The Netherlands.
Ron M A Heerenthe BioImaging MS Group, FOM Institute AMOLF, Amsterdam, The Netherlands, the M4I, The Maastricht MultiModal Molecular Imaging Institute, University of Maastricht, and.
Sander Woutersenthe Van't Hoff Institute for Molecular Sciences, University of Amsterdam, Amsterdam, s.woutersen@uva.nl.
Mireille M A E Claessensthe Nanobiophysics Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede, m.m.a.e.claessens@utwente.nl.
Vinod SubramaniamFrom the Nanoscale Biophysics Group, FOM Institute AMOLF, Amsterdam, the Nanobiophysics Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede, the Vrije Universiteit Amsterdam, De Boelelaan 1105, 1081 HV Amsterdam, The Netherlands v.subramaniam@vu.nl.ORCID http://orcid.org/0000-0001-6712-7266
Institute for Atomic and Molecular Physics · NLUniversity of Twente · NLInstitute for Molecular Science · JPUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human α-synuclein (αS) has been shown to be N terminally acetylated in its physiological state. This modification is proposed to modulate the function and aggregation of αS into amyloid fibrils. Using bacterially expressed acetylated-αS (NTAc-αS) and endogenous αS (Endo-αS) from human erythrocytes, we show that N-terminal acetylation has little impact on αS binding to anionic membranes and thus likely not relevant for regulating membrane affinity. N-terminal acetylation does have an effect on αS aggregation, resulting in a narrower distribution of the aggregation lag times and rates. 2D-IR spectra show that acetylation changes the secondary structure of αS in fibrils. This difference may arise from the slightly higher helical propensity of acetylated-αS in solution leading to a more homogenous fibril population with different fibril structure than non-acetylated αS. We speculate that N-terminal acetylation imposes conformational restraints on N-terminal residues in αS, thus predisposing αS toward specific interactions with other binding partners or alternatively decrease nonspecific interactions.

Indexed as

Membranes, ArtificialProtein AggregatesAcetylationalpha-SynucleinHumansPhospholipidsSpectrophotometry, Infraredalpha-SynucleinMembranes, ArtificialPhospholipidsProtein AggregatesSNCA protein, humanamyloidcircular dichroism (CD)lipid-protein interactionpost-translational modification (PTM)protein conformationprotein self-assembly

Identifiers

PMID27531743
PMCPMC5076520
OpenAlexW2507573110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.